Symbol
IRD on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
9.49M shares
Security Ownership
15.9%

Foundation Fighting Blindness Retinal Degeneration Fund ownership in Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD)

2025-05-06 - Foundation Fighting Blindness Retinal Degeneration Fund has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.49M shares of Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD). This represents 15.9% percent ownership of the company.